Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Total Current Liabilities (2020 - 2025)

BioAtla (BCAB) has disclosed Total Current Liabilities for 6 consecutive years, with $21.9 million as the latest value for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 50.77% year-over-year to $21.9 million; the TTM value through Dec 2025 reached $21.9 million, up 50.77%, while the annual FY2025 figure was $21.9 million, 50.77% up from the prior year.
  • Total Current Liabilities hit $21.9 million in Q4 2025 for BioAtla, up from $18.0 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $45.2 million in Q3 2021 and bottomed at $14.5 million in Q4 2024.
  • Average Total Current Liabilities over 5 years is $24.4 million, with a median of $22.5 million recorded in 2022.
  • Year-over-year, Total Current Liabilities skyrocketed 52.78% in 2023 and then plummeted 48.7% in 2024.
  • BioAtla's Total Current Liabilities stood at $19.8 million in 2021, then increased by 16.75% to $23.1 million in 2022, then grew by 22.54% to $28.3 million in 2023, then tumbled by 48.7% to $14.5 million in 2024, then surged by 50.77% to $21.9 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $21.9 million, $18.0 million, and $16.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.